Renal Insufficiency
Tenofovir-treated HIV associated with increased CKD rate for adults in Tanzania
Adults in Tanzania living with HIV and taking tenofovir have a higher rate of chronic kidney disease vs. those without the viral infection, according to a prospective cohort study.
Statin use when not indicated for certain strokes could cause adverse events
Statin initiation in patients with stroke etiologies not indicated for secondary prevention with statin therapy could hypothetically cause thousands of adverse events every year, according to a new meta-analysis published in Stroke.
No difference between liberal, restrictive transfusion strategies in acute MI, anemia
PHILADELPHIA — In patients with acute MI and anemia, there was no difference between liberal and restrictive transfusion strategies for the composite outcome of death and MI at 30 days, according to results of the MINT trial.
CAR-T safe, effective for adults with multiple myeloma and renal insufficiency
Adults with advanced multiple myeloma and renal insufficiency treated with idecabtagene vicleucel achieved similar outcomes as those with normal renal function, according to retrospective study results.
Daratumumab appears safe for patients with multiple myeloma, advanced renal insufficiency
CHICAGO — Daratumumab appeared safe for patients with multiple myeloma who had advanced renal insufficiency, according to study results presented at ASCO Annual Meeting.
New guidelines advise on diagnosis, treatment of visceral artery aneurysms
The Society of Vascular Surgery released clinical practice guidelines on management of visceral artery aneurysms, which are rare but can have grave consequences if they rupture.
Myocardial flow reserve may guide successful treatment strategy in ischemic HF
Myocardial flow reserve from PET imaging in patients with ischemic HF may identify those with a greater outcome benefit from CABG vs. PCI, according to data presented at the American College of Cardiology Scientific Session.
Romosozumab increases bone density across varying levels of renal function
ATLANTA — Romosozumab increases bone mineral density among patients with osteoporosis across different levels of renal function, according to a presenter at ACR/ARP 2019.